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Summary
 
Although it is well established that immature B lymphocytes are exquisitely sensitive to toler-
ance induction compared with their mature counterparts, the molecular basis for this difference
is unknown. We demonstrate that signaling by B cell antigen receptors leads to distinct and
mutually exclusive biologic responses in mature and immature B cells: upregulation of CD86,
CD69, and MHC class II in mature cells and receptor editing in immature cells. These re-
sponses can be induced simply by elevation of intracellular free calcium levels, as occurs after
receptor aggregation. Importantly, induction of immature B cell responses requires much
smaller increases in intracellular free calcium than does induction of mature B cell responses.
These differences in biologic response and sensitivity to intracellular free calcium likely con-
tributes to selective elimination at the immature stage of even those B cells that express low af-
finity for self-antigens.
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A
 
n essential feature of the immune system is its ability
to develop protective immunity to foreign pathogens
while remaining unresponsive to self-antigens. In the B
lymphocyte compartment, self-tolerance can be achieved
by antigen stimulation of immature B cells (1–4). Findings
that immature B cells are exquisitely sensitive to tolerance
induction compared with mature B cells (5–7) suggest that
antigen–receptor signaling may be qualitatively or quantita-
tively distinct in these populations. Although developmen-
tally programmed differences in B cells have been addressed
in a number of studies (8–10), underlying differences in sig-
nal transduction and transcriptional regulation after antigen
stimulation are unknown. Using antireceptor antibodies, it
was shown that whereas aggregation of the B cell antigen
 
receptor (BCR)
 
1
 
 induces proliferation of mature B cells
(11, 12), immature cells fail to progress beyond the early
G1 phase of the cell cycle (13) and in some cases initiate
apoptosis (14). Low to absent expression of bcl-2 may pre-
dispose immature B cells to the latter response (15). Unlike
the situation in their mature counterparts, aggregation of
the BCR on immature cells activates receptor editing via
 
induced expression of 
 
rag
 
 genes (16, 17) but fails to initiate
expression of 
 
egr-1
 
, 
 
c-fos
 
, and 
 
c-myc 
 
(12, 13).
Differential susceptibility to tolerance induction may re-
flect differences in proximal events in antigen–receptor sig-
nal transduction. In mature and immature B cells, the BCR
is composed of membrane (m)Ig noncovalently associated
with disulfide-linked heterodimers of immunoreceptor ty-
rosine-based activation motif (ITAM)-containing CD79a
and CD79b (18–20). BCR aggregation by antigen or anti-
receptor antibody mediates clustering of associated Src fam-
ily kinase molecules, leading to phosphorylation of ITAM
tyrosines. ITAM tyrosines are required for receptor-medi-
ated activation of gene expression (21), and their phosphor-
ylation leads to the recruitment of additional Src family ki-
nases as well as the tyrosine kinase Syk (22–24). Upon
recruitment, Syk becomes tyrosyl phosphorylated and acti-
vated, which is essential for activation of Btk and the phos-
 
pholipase C (PLC)
 
g
 
 pathway (23, 25). Recent studies have
defined a B cell–unique linker molecule, BLNK or Slp-65,
which serves as a substrate for Syk and is essential for the
 
activation of PLC
 
g
 
2 (26–28). Subsequent tyrosyl phosphor-
ylation of CD19 leads to phosphatidylinositol 3 kinase acti-
vation and generation of phosphatidylinositol-3,4,5-P
 
3
 
(PtdIns3,4,5P
 
3
 
) (29, 30). Phosphorylation of Btk and
PLC
 
g
 
1 and 2 and translocation of these enzymes to the
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; BM, bone
marrow; HEL, hen egg lysozyme; ITAM, immunoreceptor tyrosine-
based activation motif; PLC, phospholipase C; RAG, recombinase activa-
tor gene; Tg, transgenic. 
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plasma membrane, where they bind PtdIns3,4,5P
 
3
 
, leads to
PLC
 
g
 
1/2-mediated hydrolysis of phosphoinositides, gen-
eration of inositol-1,4,5-triphosphate (Ins1,4,5P
 
3
 
), and mo-
bilization of calcium (31–33). Comparative analysis of signal
transduction has revealed that immature B cells mobilize
intracellular calcium in response to BCR aggregation by anti-
receptor antibodies but fail to produce levels of Ins1,4,5P
 
3
 
found in mature B cells (12). These findings suggest that (a)
certain intermediary events required for antigen receptor–
mediated phosphoinositide hydrolysis are impaired in im-
mature cells and (b) immature B cell calcium stores are
more sensitive to Ins1,4,5P
 
3
 
. Neither the ability of cognate
antigen to induce distinct signal transduction responses in
these cells nor the role of these responses in determining
the unique biologic outcome of BCR signaling in imma-
ture cells has been assessed.
Here we report a comparative analysis of events after an-
tigen-induced signal transduction in mature and immature
B cells. Results indicate that antigen stimulates distinct and
mutually exclusive biologic responses in immature and ma-
ture B cells, receptor editing and upregulation of activation
markers (CD86, CD69, and MHC class II), respectively.
Both responses can be attributed to receptor-mediated ele-
vation of intracellular free calcium levels ([Ca
 
2
 
1
 
]
 
i
 
), as eleva-
tion of [Ca
 
2
 
1
 
]
 
i
 
, using agents such as ionomycin, is sufficient
to trigger them. Importantly, induction of receptor editing
in immature B cells requires much lower increases in
[Ca
 
2
 
1
 
]
 
i
 
 than does the induction of activation marker ex-
pression in mature B cells. These results demonstrate differ-
ential activation of gene expression in immature and ma-
ture B cells after BCR aggregation and that immature B
cells display increased sensitivity in the induction of these
genetic programs.
 
Materials and Methods
 
Animals and Tissue Culture.
 
B10.D2nSn/J and two Ig trans-
genic (Tg) mouse models were used in the experiments: the 3-83
 
md
 
 Ig Tg mice express IgM and IgD specific for H-2K
 
k
 
 (1), and
Ig Tg anti–hen egg lysozyme (
 
a
 
-HEL) mice express IgM and
IgD specific for HEL (2). Bone marrow (BM) was obtained from
3–4-mo-old mice; a single-cell suspension was prepared by flush-
ing femurs with IMDM to dislodge cells, followed by gentle de-
aggregation using a 5-ml syringe. BM was depleted of erythro-
cytes using Gey’s solution, washed twice in IMDM, and cultured
at 5 
 
3
 
 10
 
5
 
 cells/ml per 10-cm petri dish (7% CO
 
2
 
, 37
 
8
 
C) in
IMDM containing 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin,
50 
 
m
 
g/ml gentamycin, 2 mM 
 
l
 
-glutamine, 1 mM sodium pyru-
vate, 50 
 
m
 
M 2-ME, 10% FCS (Hyclone), and 50–100 U IL-7
(34) (derived from culture supernatant of J558L cells transfected
with mIL-7 cDNA, a gift from Dr. A. Rolink, Basel Institute for
Immunology, Switzerland). Typically, cells were harvested after
6–7 d in culture, washed twice with IMDM, and used in subse-
quent experiments. Resting splenic B cells (
 
r . 
 
1.066) were ob-
tained from 3–4-mo-old adult mice and prepared as previously
described (35). Cell viability was assessed using trypan blue dye
exclusion.
 
Reagents.
 
Antigens: an H-2K
 
k
 
 mimetic peptide (CSGFGG-
FQHLCCGAAGA) that binds specifically to the 3-83 receptor
 
(35, 36) was synthesized and multimerized by coupling to 
 
N
 
-eth-
ylmaleamide–activated dextran (a gift from CorTech, Inc.) at a
100:1 peptide/dextran molar ratio; HEL was purchased from
Sigma Chemical Co. Antibodies directed against the following
molecules were used: MHC class II (Ia
 
b/d
 
; D3.137); CD69
(H1.2F3, PharMingen); CD86 (GL-1, PharMingen); CD21/35
(CR2/CR1; 7G6, PharMingen); CD19 (1D3, PharMingen);
IgM (b-7-6); IgD (JA12.5); CD22 (CY34.1.2); CD23 (IgE Fc
receptor; B3B4, PharMingen); CD45 (I3/12.5); and CD45R
(anti-B220; RA3-3A1 and RA3-6B2). Ionomycin was purchased
from Calbiochem Corp.; propidium iodide was from Sigma
Chemical Co.
 
Phenotypic Analysis.
 
Cells were washed once, resuspended in
PBS containing 1% BSA and 0.1% sodium azide, and incubated
with an optimal amount of biotinylated or directly fluorescinated
antibody. Cells were incubated for 30 min at 4
 
8
 
C and washed
twice in PBS/BSA/azide. In the case of biotinylated antibodies,
cells were incubated as before with avidin–FITC or avidin–PE
(Becton Dickinson). After washing, cells were analyzed on a flow
cytometer. Histograms were constructed based on analysis of
10,000 cells.
 
Calcium Mobilization.
 
For measurements of [Ca
 
2
 
1
 
]
 
i
 
, cells
were loaded with Indo-1AM (Molecular Probes, Inc.), suspended
at 10
 
6 
 
cells/ml in IMDM, and stimulated with either antigen or
anti-IgM antibody (b-7-6). Mean [Ca
 
2
 
1
 
]
 
i
 
 was evaluated over
time using a flow cytometer (Model 50H; Ortho Diagnostic Sys-
tems Inc.) with appended data acquisition system and MultiTime
software (Phoenix Flow Systems) as previously described (35).
 
Analysis for Recombinase Activator Gene 2 Expression.
 
Levels of
recombinase activator gene (RAG)-2 and CD19 mRNA were
determined by RT-PCR assay as described in detail elsewhere
(34). To obtain a semiquantitative estimate of gene expression,
the signal for RAG-2 was normalized to the CD19 signal.
 
Results and Discussion
 
Analysis of molecular mechanisms underlying the re-
sponses of immature and mature B cells to antigen required
generation of homogeneous populations of antigen-specific
cells. To generate antigen-specific immature B cells, cells
were isolated from BM of 3-83 
 
md
 
 (specific for H-2K
 
k
 
) Ig
Tg (1) or 
 
a
 
-HEL Ig Tg (2) mice and cultured for 6–7 d
in IL-7–containing medium. Over this period, the total
number of cells per dish increased from 5 
 
3
 
10
 
6
 
 to 30–40 
 
3
 
10
 
6
 
 (data not shown). The percentage of B cells (CD45R
 
1
 
)
increased from 12–18% at the onset of the culture to 
 
.
 
95%
after 5 d, demonstrating the selective outgrowth of IL-7–
responsive B cell precursors (34, 37). Phenotypic analysis
further indicated that few cells from non-Tg BM grown
in IL-7 progressed to the IgM
 
1
 
IgD
 
2
 
 immature B cell stage
compared with the Ig Tg animals (Fig 1). Cells from Tg
BM grown under these conditions were 
 
.
 
90% IgM
 
low
 
IgD
 
2
 
; upon removal of IL-7, cells progressed through
IgM
 
high
 
IgD
 
2
 
, the immature stage, to IgM
 
high
 
IgD
 
low
 
, the
transitional stage, and finally to mature B cells (data not
shown and reference 34). Relative expression of mIgM and
mIgD transgenes as well as other markers was consistent
with development of a homogeneous population of imma-
ture cells in these cultures (Fig. 1): cells were CD45
 
low
 
 (also
CD45R
 
low
 
, not shown), CD22
 
low
 
, and CD19
 
low
 
 (all com- 
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pared with mature B cells), whereas they were negative for
CD21/35 and CD23, which are only expressed on mature
B cells (38–40). Equivalent phenotypes were seen when
BM cells from 
 
a
 
-HEL Tg animals were grown in IL-7
(data not shown). These data confirm a previous report
(34) that the presence of mIgM transgenes is sufficient to
accelerate B cell maturation through the pro- and pre-B
cell stages to an immature phenotype. Although it is diffi-
cult to exclude the possibility that the cells grown in this
system are developmentally pre-B cells that simply express
a Tg BCR on their surfaces, these cells express all known
markers associated with the immature B cell stage (41, 42).
We then compared early biologic responses of the re-
spective B cell populations to antigen, analyzing induction
of 
 
rag
 
 gene expression, indicative of clonal elimination by
receptor editing (3), and CD69, CD86, and MHC class II
expression, indicative of BCR signal transduction leading
to initiation of an immune response. Immature B cells from
BM cultures and mature splenic B cells from 3-83 
 
md
 
 or
 
a
 
-HEL Tg animals were incubated with antigen, and the ex-
pression of activation markers was assessed (Fig. 2 A). Ma-
ture B cells upregulated CD69, CD86, and MHC class II
molecules within 12 h of stimulation, as previously shown
(43–45). In immature 3-83 
 
md
 
 Tg cells, however, only
slight upregulation of CD69 and CD86 was detected, and
this was seen only at 12 h after stimulation. HEL stimula-
tion of immature, 
 
a
 
-HEL Tg cells also led to upregulation
of these markers at 12 h. The responses were more pro-
 
nounced than those of immature 3-83 
 
md
 
 cells but much
less than those of mature 
 
a
 
-HEL Tg B cells (Fig. 2 A). No
antigen induction of MHC class II was observed in imma-
ture cells. The difference in the degree of upregulation be-
tween the 3-83 
 
md
 
 and 
 
a
 
-HEL Tg cells is probably due to
the affinity of the transgene-encoded receptor for its ligand
(
 
z
 
2 
 
3
 
 10
 
2
 
5 
 
M for 3-83 
 
md
 
 [reference 46] and 2 
 
3
 
 10
 
2
 
9 
 
M
for 
 
a
 
-HEL [reference 2]). These results demonstrate that
immature B cells are unable to effectively upregulate mole-
cules essential for T–B cell collaboration; this probably pre-
vents their participation in T cell–dependent immune re-
sponses.
Recent studies demonstrate that binding of antigen to
mIgM on immature B cells induces recombinase gene ex-
pression and L chain receptor rearrangements (16, 17), a
process that results in alteration of receptor specificity,
termed receptor editing (3). This process leads to clonal
elimination of immature cells but may also contribute to
increasing diversity in a germinal center reaction (47). To
compare the ability of immature and mature B cells to un-
dergo a receptor editing response to antigen, we tested for
antigen-induced reactivation of 
 
rag
 
 genes using RT-PCR.
These analyses demonstrated a greater than twofold (nor-
malized to CD19 mRNA levels) increase in RAG-2 ex-
pression upon antigen stimulation in immature cells (Fig. 2
B), resembling responses observed in vivo (3). No RAG-2
mRNA was detectable in mature B cells before or after 18-h
antigen stimulation. Finally, no antigen-induced cell death
Figure 1. Generation of immature B cells in BM cultures containing IL-7. B cells isolated from BM from 3-83 md Tg and non-Tg littermate mice
(B10.D2) were cultured for 7 d in the presence of IL-7. Cells, as well as mature splenic B cells, were analyzed by flow cytometry. Negative control his-
tograms are shown as dashed lines. Shown in the upper right corner of each panel is the percentage of cells positive for the respective marker along with
the relative mean fluorescence intensity (MFI). 
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was observed over the 18-h period in mature or immature
cells (data not shown). Thus, as previously shown (16), an-
tigen-induced cross-linking of the BCR in immature cells
results in the induction of receptor editing, and this re-
sponse is not seen in mature, naive B cells. Together, the
data demonstrate two mutually exclusive response patterns
in mature and immature cells. These distinct patterns may
ensure that autoreactive, immature B cells do not mature
into autoreactive, mature B cells and that only B cells that
have been properly vetted to eliminate those that are au-
toreactive can effectively upregulate ligands for CD28
(CD86) and T cell antigen receptor (MHC class II) and
thus participate in a productive immune response.
The observed differences in the biologic responses of
mature and immature cells may result from differences in
BCR coupling to proximal signal transduction pathways.
Alternatively and/or additionally, these B cells may be pro-
grammed to respond differently to the same constellation of
 
“second” messengers. Calcium mobilization plays an im-
portant role in triggering a wide array of cellular processes
(48), including RAG induction (49), and could drive the
BCR-mediated expression for CD69, MHC class II, and
CD86. To determine if calcium mobilization is sufficient to
initiate the biologic responses of immature and mature B
cells, ionomycin was used to induce graded rises in the in-
tracellular free Ca
 
2
 
1
 
 concentration ([Ca
 
2
 
1
 
]
 
i
 
). Ionomycin
induced comparable increases in [Ca
 
2
 
1
 
]
 
i
 
 in immature and
mature B cells at each concentration used (Fig. 3 A). Anal-
ysis of marker induction after 18 h of ionomycin stimula-
tion demonstrated profound upregulation of CD86 in ma-
ture B cells but only at doses of ionomycin that induced
increases of .600 nM [Ca21]i; small increases were ob-
served at doses that raised [Ca21]i by 80–120 nM, and no
upregulation was seen when [Ca21]i was raised by 50 nM
(Fig. 3 B). Consistent with the effects of antigen (Fig. 2),
ionomycin did not induce CD86 in immature B cells. Sim-
ilar observations were made for MHC class II and CD69
(data not shown). This demonstrates the sufficiency of cal-
cium mobilization in antigen activation of CD86 and
MHC class II expression in mature B cells.
As previously reported (49), elevation of [Ca21]i induced
RAG-2 expression in immature B cells. However, as
shown in Fig. 3, this response followed much smaller in-
creases in [Ca21]i than required to induce CD86 in mature
cells: RAG-2 expression was increased 1.7–2.3-fold after
80–120-nM rises in [Ca21]i and 3.1–5-fold after a 50-nM
rise in [Ca21]i (Fig. 3 C). High doses of ionomycin (induc-
ing .600 nM increase in [Ca21]i) only raised RAG-2 mar-
ginally and were accompanied by an increased apoptotic
response (two- to threefold increase over unstimulated
control), whereas little to no apoptosis was induced at 100
and 10 nM ionomycin (data not shown and reference 49).
This suggests that extreme increases in [Ca21]i in immature
B cells (possibly reflecting a signal through a high-avidity
interaction with self-antigen) leads to an apoptotic rather
than a receptor editing response. No RAG-2 induction
was detected in mature B cells. These data demonstrate that
increases in [Ca21]i can mediate the unique, antigen-induced
changes in CD86 and RAG-2 seen in mature and imma-
ture B cells, respectively. These distinct biologic responses
could be generated via two mechanisms. First, BCR stimu-
lation could lead to activation of different transcription fac-
tors that are developmental stage specific in their expres-
sion. Second, different genetic loci could be more accessible
in immature and mature B cells by regulated demethylation
and chromatin remodeling; it has been demonstrated that
these processes are involved in differential induction of egr-1
in immature versus mature B cells (9), allelic exclusion dur-
ing B cell development (10), and regulation of cytokine
gene expression in Th1 and Th2 cells (50). According to
this model, BCR stimulation would activate calcium-depen-
dent transcription factors (e.g., NFAT [nuclear factor of
activated T lymphocytes]), leading to rapid transcription of
the accessible loci in each cell type; these would include rag
in immature cells and CD86 and MHC class II in mature
cells. The ability of HEL to induce transient upregulation
Figure 2. Antigen induces qualitatively distinct biologic responses in
immature and mature B cells. (A) Expression of CD69, CD86, and MHC
class II was analyzed in immature and mature B cells from 3-83 md and
a-HEL Tg animals after stimulation with peptidic 3-83 antigen–dextran
conjugates (500 ng/106 cells) or HEL (1,000 ng/106 cells), respectively for
0 (dotted lines), 12 (dashed lines), or 24 h (bold lines); surface expression
of markers was monitored by immunofluorescence with analysis by flow
cytometry. (B) RT-PCR analysis of RAG-2 and CD19 mRNA in im-
mature and mature B cells from 3-83 md and a-HEL Tg animals before
and after 18-h stimulation with their respective antigens.753 Benschop et al.
of CD86 in immature cells appears inconsistent with both
of these hypotheses. The high frequency of cells displaying
this response excludes the possibility that it is a consequence of
contaminating mature cells. It is possible that the accessibil-
ity of the loci is not absolute. Perhaps a sufficiently strong
antigen receptor signal can lead to some expression of a rel-
atively inaccessible locus. More studies are required to re-
solve this question.
The observations presented here are consistent with the
behavior of the 3-83 md Ig Tg model of tolerance induc-
tion wherein immature B cells encounter autoantigen in
the BM and are induced to edit their receptors (1, 3).
However, they appear inconsistent with the HEL/a-HEL
model. Specifically, findings that HEL induces RAG in im-
mature B cells from a-HEL mice predict that B cells in
HEL/a-HEL double-Tg mice should undergo editing in
vivo. Evidence for receptor editing is observed when HEL
is expressed in a membrane-associated form (51) but is less
obvious when HEL is present as a secreted protein (2). In
the latter double-Tg animals, however, a decline in the
number and frequency of HEL-specific B cells is observed,
suggesting that a portion of B cells may have been deleted
(e.g., the IgMhigh cells) (2). It is possible that soluble HEL
may not reach sufficient concentrations in the BM milieu
to generate a strong enough signal to induce RAG in most
developing B cells. Upon exiting the BM, B cells would
encounter concentrations of soluble HEL in the periphery
sufficient to render them anergic. Considering that the sol-
uble HEL Tg is under the control of a metallothionein
promoter, highest secretion of soluble HEL would be ex-
pected in the liver, kidney, or pancreas (52, 53). Thus, it is
conceivable that immature B cells would only encounter
low concentrations of soluble HEL in the BM. In addition,
it could be hypothesized that only a limited number of B
cells (e.g., only IgMhigh B cells) receive a signal strong
enough to induce receptor editing; these cells are then ei-
ther deleted or successfully edited away from their specific-
ity for HEL but are not seen in vivo because of the size of
the anergic B cell population. Mice expressing Ig Tg recep-
tors for another soluble but multivalent ligand, DNA, dem-
onstrate that B cells are rendered anergic when recognizing
single-stranded DNA (low affinity), whereas B cells bind-
ing double-stranded DNA (high affinity) are deleted (4,
54). This supports the hypothesis that antigen valency in
combination with receptor affinity determines the mecha-
nism of tolerance induction in immature B cells. Resolu-
tion of these and other alternatives awaits further study.
The data presented also demonstrate a clear difference in
sensitivity of the responses of mature and immature B cell
to rises in intracellular calcium. Differences in these re-
sponses may be linked to the observed difference in toler-
ance sensitivity (5–7), where low signals in immature B
Figure 3. Calcium elevation induces RAG-2 expression in immature B cells and CD86 in mature B cells, and these responses exhibit different sensi-
tivities to [Ca21]i. (A) [Ca21]i was measured in immature and mature B cells from 3-83 md Tg animals after stimulation with ionomycin. (B) Immature
(filled bars) and mature (open bars) B cells from 3-83 md and a-HEL Tg animals were stimulated with varying doses of ionomycin (10–1,000 nM) or
their respective antigens (500 ng peptidic 3-83 antigen–dextran/106 cells and 1,000 ng/ml HEL) for 18 h; induction of CD86 is expressed as fold increase
in mean fluorescence intensity over unstimulated control. (C) RT-PCR analysis of mRNA expression of RAG-2 was normalized to that of CD19; in-
duction of RAG-2 is expressed as fold increase over unstimulated control. Asterisks indicate absence of data because RAG-2 could not be detected in
mature B cells before or after ionomycin. Results are representative of three experiments.754 BCR Signaling in Immature B Cells
cells (induced by a low antigen concentration) result in
clonal elimination, presumably by receptor editing. Simi-
larly, the higher signal threshold for activation of mature B
cells in the periphery protects against autoimmunity by
preventing activation of mature B cells with low affinity for
self. The question remains whether BCR-proximal signal
transduction events differ between immature and mature B
cells. It will be especially important to assess differences
pertaining to the generation of Ca21 mobilization, as this
leads to the activation of specific genes. The increased sen-
sitivity to antigen imposed by these mechanisms in imma-
ture B cells is likely to play a very important role in reper-
toire development, purging the repertoire of cells with
even low affinities for self-antigens.
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